Abbott Labs Newswire

Abbott Labs Newswire

Comprehensive Real-Time News Feed for Abbott Labs.

Results 1 - 20 of 1,013 in Abbott Labs

  1. Europe Uterine Cancer Therapeutics Market is expected to reach USD 6,996.1 million by 2021Read the original story

    Friday May 26 | Emailwire.com

    Europe Uterine Cancer Therapeutics Market by Type and by Therapy- Industry Analysis, Size, Share, Growth, Trends, and Forecasts As per the syndicated report published by Market Data Forecast, Europe Uterine Cancer Therapeutics Market which is estimated to be USD 5393.8 million in 2016 and expected to grow at a CAGR of 5.34%, to reach USD 6996.1 million by 2021 with a cumulative growth rate of USD 1602.3 billion in the span of five years. It can attributed to the factors such as advancements in technology to develop innovative cancer therapy solutions, increasing number of newly diagnosed uterine cancer cases, and rising government support to develop effective therapeutics.

    Comment?

  2. How Abbott Will Benefit From Its Alere AcquisitionRead the original story

    Thursday May 25 | BioSpace

    On April 14, 2017, Abbott Laboratories agreed to acquire point-of-care diagnostics player Alere for an equity value of ~$5.3 billion, ~$500 million lower than the price decided for Alere on January 31, 2016. The existing terms of the agreement had to be amended after multiple regulatory and legal issues related to Alere were discovered following the original announcement of the acquisition.

    Comment?

  3. Myoplex ShredRead the original story w/Photo

    Apr 5, 2017 | Beverage Industry

    EAS, a brand of Abbott Laboratories, introduced a new high-protein, ready-to-drink nutrition shake: Myoplex Shred. The product is designed to meet athletes' needs by delivering 42 grams of slow- and fast-digesting protein to feed muscles for up to six hours, the company says.

    Comment?

  4. Europe transcatheter aortic valve replacement (TAVR) market is...Read the original story

    Friday May 26 | Emailwire.com

    Europe transcatheter aortic valve replacement market is expected to reach USD 1.06 billion by 2021 from USD 0.47 billion in 2016, growing at a CAGR of 17.40% during the forecast period 2016-2021. Europe transcatheter aortic valve replacement market is segmented based on surgery method, valve frame material, valve size, valve leaflets material, and end users.

    Comment?

  5. Immunoassay Reagents Industry - Global MarketExpert Opinions...Read the original story w/Photo

    Thursday May 25 | SBWire

    To highlight the market trend and status, Market Research Report Search Engine has recently added an analyzed the latest report titled as " Immunoassay Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024". An immunoassay is a biochemical test that measures the presence of concentration of macromolecules in the solution through the use of immunoglobulin or antibody.

    Comment?

  6. Murphy Capital Management Inc. Has $987,000 Stake in Abbott LaboratoriesRead the original story w/Photo

    Thursday May 25 | IntersportsWire

    Murphy Capital Management Inc. boosted its stake in shares of Abbott Laboratories by 75.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,242 shares of the healthcare product maker's stock after buying an additional 9,536 shares during the period.

    Comment?

  7. Pacific Center for Financial Services Buys iShares Core S&P Small-Cap, Vanguard Total ...Read the original story w/Photo

    Thursday May 25 | GuruFocus.com

    Investment company Pacific Center for Financial Services buys iShares Core S&P Small-Cap, Vanguard Total International Stock ETF, Powershares FTSE RAFI US 1000 Portfolio, iShares Core S&P Mid-Cap, SPDR Series Trust S&P Biotech, Sempra Energy, Bank of America Corporation, Allergan PLC, iShares Edge MSCI Min Vol Global, Honeywell International Inc, sells Vanguard Intermediate-Term Bond, Guggenheim S&P 500 Pure Growth, Vanguard Short-Term Bond, Berkshire Hathaway Inc, JPMorgan Chase Capital XVI JP Morgan Alerian MLP E during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Pacific Center for Financial Services.

    Comment?

  8. Abbott Labs Issues Recall for HeartMate II Lvas ControllerRead the original story w/Photo

    Thursday May 25 | GuruFocus.com

    After recalling its Thoratec HeartMake II LVAS controller on May 24, Abbott Laboratories shares declined 15 cents or 0.34%, closing at $43.53 per share. The U.S. Food and Drug Administration said the company recalled 29,000 devices after receiving 70 incidence reports where the controller malfuctioned after being switched out, including 19 injuries and 26 deaths.

    Comment?

  9. McDonald'sRead the original story w/Photo

    Wednesday May 24 | Seeking Alpha

    The information in this presentation contains certain forward-looking statements that reflect management's expectations regarding future events and operating performance and speak only as of May 24, 2017. These forward-looking statements are not guarantees of performance and involve a number of risks and uncertainties.

    Comment?

  10. 26 Deaths Tied to Abbot Blood PumpRead the original story w/Photo

    Wednesday May 24 | News Max

    At least 26 heart failure patients have died after trying to replace the controller for their HeartMate II blood pumps while out of the hospital, according to a news report. Abbott Laboratories issued an alert for 28,882 HeartMate II controllers that includes new software and alarm guides, following reports of 70 incidents in which the device malfunctioned after a patient changed out the controller at home, the Star Tribune reports.

    Comment?

  11. Eleanor C. BrooksRead the original story

    Wednesday May 24 | Peshtigo Times Wisconsin Community Newspaper

    Eleanor C. Brooks, 98, of Wallace, Mi., formerly of Waukegan, Ill., passed away Thursday, May 18, 2017 at River Breeze Adult Care Center.

    Comment?

  12. 26 Patients Dead After Replacing Controller for Abbott's HeartMate II Blood Pumps at HomeRead the original story

    Tuesday May 23 | BioSpace

    At least 26 patients with advanced heart failure have died after trying to replace the controller for their HeartMate II blood pumps while out of the hospital. Abbott Laboratories has issued a device alert for 28,882 HeartMate II controllers that includes new software and alarm guides, following reports of 70 incidents in which the life-preserving device has malfunctioned after a patient changed out the controller at home.

    Comment?

  13. Dominating the Market Today: Abbott Laboratories,Read the original story

    Feb 24, 2017 | The Daily Leicester

    Friday February 24th 2017: Abbott Laboratories, ABT is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Abbott Laboratories, ABT has a market cap of 75.48 B. Since its IPO date on the 04/06/1983, Abbott Laboratories, ABT performance year to date is 13.72%.

    Comment?

  14. Abbott Laboratories (ABT) Lowered to "Hold" at Zacks Investment ResearchRead the original story w/Photo

    Wednesday May 24 | AmericanBankingNews.com

    According to Zacks, "Over the last three months, Abbott is trading below the broader Medical Products industry. While, sluggish pediatric business in China continues to hamper growth, we are also worried about the on-going economic problem in Venezuela that is expected to remain unresolved in the coming quarters.

    Comment?

  15. 26 patients have died after replacing controller for Abbott blood pump at homeRead the original story w/Photo

    Wednesday May 24 | Star Tribune

    At least 26 patients with advanced heart failure have died after trying to replace the controller for their HeartMate II blood pumps while out of the hospital. Abbott Laboratories has issued a device alert for 28,882 HeartMate II controllers that includes new software and alarm guides, following reports of 70 incidents in which the life-preserving device has malfunctioned after a patient changed out the controller at home.

    Comment?

  16. Organic Baby Food Market 2016 to 2027 - " Production, Market Analysis, Growth, Trends and ForecastsRead the original story w/Photo

    Wednesday May 24 | World News Report

    Organic Baby Food Market Analysis Product Type , Ingredients , Distribution Channel and Region - Forecast to 2027 Major Key Players are Danone S.A. , Hero Group , Abbott Laboratories , Kraft Heinz Foods Company , Nestle S.A. " PUNE, MAHARASHTRA, INDIA, May 24, 2017 / EINPresswire.com / -- Market Research Future published a Cooked Research Report on Global Organic Baby Food Market value which is estimated to grow at 11.73% by 2027. Organic baby food is nothing but soft, and easily consumable food, other than breast milk or infant formula which comes in diverse formulation and multiple varieties and tastes.

    Comment?

  17. National Pension Service Buys 173,031 Shares of Abbott LaboratoriesRead the original story w/Photo

    Tuesday May 23 | IntersportsWire

    National Pension Service boosted its stake in shares of Abbott Laboratories by 17.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,184,114 shares of the healthcare product maker's stock after buying an additional 173,031 shares during the period.

    Comment?

  18. Abbott Laboratories (ABT) Price Target Cut to $50.00Read the original story w/Photo

    Tuesday May 23 | IntersportsWire

    The brokerage currently has a buy rating on the healthcare product maker's stock. A number of other equities research analysts also recently issued reports on ABT.

    Comment?

  19. Quotient Investors LLC Has $546,000 Position in Abbott LaboratoriesRead the original story w/Photo

    Tuesday May 23 | IntersportsWire

    Quotient Investors LLC increased its stake in shares of Abbott Laboratories by 17.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,300 shares of the healthcare product maker's stock after buying an additional 1,800 shares during the period.

    Comment?

  20. Ultimate Stock-Pickers: Top 10 High-Conviction and New-Money PurchasesRead the original story w/Photo

    Tuesday May 23 | Morningstar

    For the past nine years, our primary goal with the Ultimate Stock-Pickers concept has been to uncover investment ideas that not only reflect the most recent transactions of our grouping of top investment managers , but are also timely enough for investors to get some value from them. In cross-checking the most current valuation work and opinions of Morningstar's own cadre of stock analysts against the actions of some of the best equity managers in the business, we hope to uncover a few good ideas each quarter that investors can dig a bit deeper into to see if they warrant an investment.

    Comment?